Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

Summary Background Adherence is an overall marker of treatment success, and it depends on multiple factors including efficacy and safety. Despite the wide use of tumour necrosis factor (TNF)‐α blockers in the treatment of plaque‐type psoriasis, few data regarding treatment adherence in routine clini...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	British journal of dermatology (1951) Ročník 169; číslo 3; s. 666 - 672
Hlavní autoři:	Esposito, M., Gisondi, P., Cassano, N., Ferrucci, G., Del Giglio, M., Loconsole, F., Giunta, A., Vena, G.A., Chimenti, S., Girolomoni, G.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Oxford Blackwell Publishing Ltd 01.09.2013 Wiley-Blackwell
Témata:	Adalimumab Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Biological and medical sciences Dermatologic Agents - therapeutic use Dermatology Etanercept Female Humans Immunoglobulin G - therapeutic use Immunologic Factors - therapeutic use Infliximab Kaplan-Meier Estimate Male Medical sciences Medication Adherence Middle Aged Psoriasis - drug therapy Psoriasis - mortality Psoriasis. Parapsoriasis. Lichen Receptors, Tumor Necrosis Factor - therapeutic use Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult Antineoplastic agent Skin disease Observational study Prognosis Treatment Psoriasis Dermatology Multicenter study Rate Survival Necrosis
ISSN:	0007-0963, 1365-2133, 1365-2133
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!